Avid Bioservices Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Year	2023	2022	2021	2020	2019	2018 - 1994
Revenue	149.27	119.6	95.87	59.7	53.6	Upgrade
Revenue Growth (YoY)	24.81%	24.75%	60.58%	11.38%	-0.03%	Upgrade
Cost of Revenue	117.79	82.95	66.56	55.77	46.38	Upgrade
Gross Profit	31.48	36.65	29.31	3.93	7.22	Upgrade
Selling, General & Admin	27.88	21.23	17.06	14.52	12.85	Upgrade
Other Operating Expenses	0	0	0	0.36	0	Upgrade
Operating Expenses	27.88	21.23	17.06	14.87	12.85	Upgrade
Operating Income	3.6	15.42	12.24	-10.94	-5.62	Upgrade
Interest Expense / Income	3.01	2.68	1.16	0.01	0.01	Upgrade
Other Expense / Income	-1	0.08	-0.13	-0.48	-1.13	Upgrade
Pretax Income	1.59	12.66	11.21	-10.47	-4.5	Upgrade
Income Tax	1.33	-115.01	0	0	-0.28	Upgrade
Net Income	0.26	127.67	11.21	-10.47	-4.22	Upgrade
Preferred Dividends	0	0	7.89	4.69	4.69	Upgrade
Net Income Common	0.26	127.67	3.32	-15.15	-8.9	Upgrade
Net Income Growth	-99.80%	3747.86%	-	-	-	Upgrade
Shares Outstanding (Basic)	62	61	58	56	56	Upgrade
Shares Outstanding (Diluted)	64	70	59	56	56	Upgrade
Shares Change	-9.50%	18.59%	5.50%	0.62%	18.95%	Upgrade
EPS (Basic)	-	2.08	0.06	-0.27	-0.16	Upgrade
EPS (Diluted)	-	1.84	0.06	-0.27	-0.16	Upgrade
EPS Growth	-	2966.67%	-	-	-	Upgrade
Free Cash Flow	-90.53	-46.95	21.32	2.02	-7.05	Upgrade
Free Cash Flow Per Share	-1.45	-0.76	0.37	0.04	-0.13	Upgrade
Gross Margin	21.09%	30.64%	30.57%	6.59%	13.48%	Upgrade
Operating Margin	2.41%	12.89%	12.77%	-18.32%	-10.49%	Upgrade
Profit Margin	0.17%	106.75%	3.46%	-25.38%	-16.61%	Upgrade
Free Cash Flow Margin	-60.65%	-39.25%	22.24%	3.38%	-13.15%	Upgrade
Effective Tax Rate	83.71%	-908.39%	-	-	-	Upgrade
EBITDA	11.81	19.82	15.83	-7.37	-1.74	Upgrade
EBITDA Margin	7.91%	16.57%	16.51%	-12.34%	-3.25%	Upgrade
Depreciation & Amortization	7.21	4.48	3.45	3.09	2.75	Upgrade
EBIT	4.6	15.34	12.38	-10.46	-4.49	Upgrade
EBIT Margin	3.08%	12.83%	12.91%	-17.52%	-8.37%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).